Uppsala professor warns TBE vaccine may need updating

TBE cases in Sweden have tripled over ten years despite rising vaccinations. Åke Lundkvist, professor of virology at Uppsala University, suspects the virus may have changed, reducing vaccine effectiveness. Researchers are now analyzing 12,000 ticks to investigate.

The number of reported TBE cases in Sweden has risen sharply over the past ten years. According to Folkhälsomyndigheten, cases increased from 238 in 2016 to 504 in 2025, with peaks like 595 in 2023 and a low of 274 in 2020. Vaccinations have risen at a similar pace.

Åke Lundkvist, professor of virology at Uppsala University, describes the trend as suspicious. "Something is fishy," he told SVT Nyheter. He suggests the vaccine may be losing effectiveness if the TBE virus has mutated. "The vaccine can become less effective if the virus causing the infection changes," Lundkvist explained.

To clarify, around 12,000 ticks collected by the Swedish public are being sent to Statens veterinärmedicinska anstalt (SVA). They will be analyzed in collaboration with Uppsala University's Zoonoscentret to compare current virus strains with those from previous years and the basis for existing vaccines.

Lundkvist stresses the need for vaccination. "Absolutely not [skip getting vaccinated], the vaccine works and it is the only important remedy we have today. We will find out if it can be even better," he said. The research aims to rule out other causes for the rise.

Artikel Terkait

Illustration of a crowded Swedish hospital amid flu surge, with rising case stats displayed.
Gambar dihasilkan oleh AI

Number of influenza cases surges in Sweden

Dilaporkan oleh AI Gambar dihasilkan oleh AI

Influenza has truly arrived in Sweden. In the first week of the year, 2,131 cases were confirmed, a 22 percent increase from the end of the previous week. The spread is assessed as medium-high level, according to the Public Health Agency.

Flu cases in Sweden have doubled every week since mid-November, driven by the new K variant of the influenza virus. The Public Health Agency reports a rapid increase, with cases rising from 403 to 808 in one week. Severe cases, including deaths and intensive care admissions, have also risen from low levels.

Dilaporkan oleh AI

Researchers in China have developed a potent antibody that could combat severe fever with thrombocytopenia syndrome (SFTS), a tick-borne disease with a mortality rate of up to 30 percent. The discovery offers new hope for tackling this growing threat in East Asia.

The meningitis outbreak in Canterbury, Kent, UK, has escalated with 29 infections and two deaths, prompting mass vaccinations and antibiotics distribution. Authorities warn of possible spread beyond Kent, while Swedish experts advise vigilance.

Dilaporkan oleh AI Fakta terverifikasi

Ilmuwan di University of Queensland telah menangkap gambar 3D pertama dengan resolusi hampir atomik dan resolusi tinggi dari virus demam kuning, merinci bagaimana permukaan strain vaksin yang telah lama digunakan berbeda dari strain virulen penyebab penyakit. Pekerjaan ini menerangi bagaimana virus dikenali oleh sistem kekebalan dan dapat mendukung vaksin yang lebih baik untuk demam kuning dan penyakit bawaan nyamuk terkait.

Peneliti di UC San Francisco menemukan bukti yang menunjukkan bagaimana virus Epstein-Barr dapat memicu respons imun pada pasien multiple sclerosis. Studi tersebut mengungkapkan tingkat sel imun yang menargetkan virus yang lebih tinggi di sistem saraf mereka. Temuan ini, yang diterbitkan di Nature Immunology, menunjukkan jalur pengobatan baru potensial dengan menargetkan virus tersebut.

Dilaporkan oleh AI

Infeksi campak di Amerika Serikat mencapai level tertinggi dalam lebih dari tiga dekade tahun lalu, dengan 2.242 kasus terkonfirmasi. Wabah yang melonjak di South Carolina, yang telah menginfeksi lebih dari 600 orang sejak Oktober, mengancam melampaui insiden besar di West Texas. Perkembangan ini menandakan tahun lain yang menantang bagi kesehatan masyarakat.

 

 

 

Situs web ini menggunakan cookie

Kami menggunakan cookie untuk analisis guna meningkatkan situs kami. Baca kebijakan privasi kami untuk informasi lebih lanjut.
Tolak